United Nations is the most frequent co-covered peer, appearing in 2 of the 4 tracked stories. Coverage clusters in regulation, which accounts for 3 of those 4, with the remainder spread across 1 other category. Each story carries 2 original sources on average, compared with 3.8 for the broader beat in this window.
Coverage balanceBalanced directional read. Positive and negative coverage are within 0 percentage points.
25% positive
50% neutral
25% negative
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about UNICEF
United Nations is the most frequent co-covered peer, appearing in 2 of the 4 tracked stories. Coverage clusters in regulation, which accounts for 3 of those 4, with the remainder spread across 1 other category. Each story carries 2 original sources on average, compared with 3.8 for the broader beat in this window. The 150-day window averages about 0.2 stories each week. Their average consequence score of 6 runs below the beat's 6.1 for that window. This profile follows 4 Healthcare stories mentioning UNICEF across the period from March 11, 2026 to August 7, 2026.
Stories tracked
4
Per week
0.2
Sources per story
2
Computed from the 4 stories linked to this entity, with beat comparisons drawn from all 709 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering UNICEF. Shared-story counts are live from our verified record — not editorial picks.
The Cuban health system is reeling from U.S. sanctions, with child cancer survival falling from 85% to 65%, 100,000 children losing daily milk, and vaccine programs at risk. The report details a sweeping healthcare collapse affecting surgery, dialysis, and essential medicines.
DCGI's authorization of QDENGA brings India its first dengue vaccine, a no‑screening option that could reshape public health strategy. With the country bearing a third of the world's dengue cases, the vaccine promises to reduce hospitalizations and ease endemic pressure on healthcare systems.
Despite a slight uptick in global infant vaccination rates, 13.5 million children received no vaccines in 2025. The UN warns that dropout rates and misinformation are creating dangerous gaps, threatening public health gains and demanding smarter health system responses.
GC Biopharma has published a landmark review paper detailing three decades of clinical and real-world data for its proprietary MAV/06 varicella vaccine strain. The publication underscores the strain's long-term safety and efficacy, positioning it as a primary global alternative to the widely used Oka strain.